Age-Dependent Interplay of Modifiable Risk Factors and Genetic Risk in Pancreatic Cancer
Pancreatic cancer remains one of the most serious cancers because it is often diagnosed late and has a poor prognosis. Understanding who is at higher risk is essential for prevention, early detection, and future screening strategies. A new cohort study using data from the UK Biobank examined how inherited genetic risk and lifestyle-related risk factors interact across different age groups in pancreatic cancer.
Why this study matters
Some people are born with a higher inherited susceptibility to pancreatic cancer, while others develop elevated risk because of modifiable factors such as smoking, heavy alcohol use, poor diet, inactivity, obesity, diabetes, and pancreatitis. In real life, these risks do not act separately. The key question is whether modifiable risk factors matter more at certain ages and whether their impact changes depending on a person’s genetic risk.
This is important for public health because if lifestyle factors are especially influential in younger adults, prevention efforts may need to begin earlier in life, particularly for those with higher inherited risk.
Study design and participants
This was a prospective, population-based cohort study. Researchers analyzed data from 290,645 participants in the UK Biobank who were enrolled between 2006 and 2010 and followed for a median of 11.7 years. The analysis period ran from January to September 2025. The average age at baseline was 56.1 years, and 51.6% were men.
The main outcome was incident pancreatic cancer, meaning new cases that occurred during follow-up. These cases were identified through linkage with national health registries, which strengthens the reliability of outcome capture.
How risk was measured
The researchers assessed two types of risk scores:
1. Polygenic Risk Score (PRS): This reflects inherited genetic susceptibility based on many common genetic variants, each contributing a small amount of risk.
2. Modifiable Risk Score (MRS): This summarized lifestyle and health factors that can potentially be changed. The MRS included smoking, excessive alcohol intake, unhealthy diet, physical inactivity, overweight, diabetes, and pancreatitis.
For both scores, participants were grouped into low, intermediate, and high categories. The researchers then studied how these scores related to pancreatic cancer risk in three age bands: younger than 60 years, 60 to 69 years, and 70 years or older.
Main findings
During follow-up, 1,187 participants developed pancreatic cancer, which represented 0.41% of the cohort. Both genetic risk and modifiable risk were associated with pancreatic cancer, but the strength of these associations differed by age.
The PRS was associated with a higher risk of pancreatic cancer across all age groups. Specifically, for every 1-standard-deviation increase in PRS, the hazard ratio was 1.39 in people younger than 60 years, 1.66 in those aged 60 to 69 years, and 1.37 in those aged 70 years or older. The interaction between PRS and age was not statistically significant, suggesting that genetic risk increased pancreatic cancer risk in a fairly consistent way across ages.
In contrast, the MRS showed a stronger association with pancreatic cancer in younger adults than in older adults. For every 1-point increase in MRS, the hazard ratio was 1.69 among participants younger than 60 years, compared with 1.25 in those aged 60 to 69 years and 1.20 in those aged 70 years or older. This age interaction was statistically significant, indicating that modifiable risk factors had a more pronounced impact earlier in life.
What the cumulative incidence results showed
The study also estimated standardized 10-year cumulative incidence (SCI), expressed per 100,000 people. This provides a more intuitive sense of absolute risk over time.
Across all genetic risk groups, higher MRS levels were associated with higher pancreatic cancer incidence. In younger adults under 60, the pattern was especially striking. People with high PRS but low MRS had a lower SCI, 38.2 events per 100,000 persons, than people with low PRS but high MRS, who had 92.2 events per 100,000 persons. In other words, unfavorable lifestyle and health factors could outweigh inherited risk in absolute terms for some younger individuals.
The difference in SCI between high and low MRS groups was largest among those with high genetic risk. In this high-PRS group, the incidence difference was 6.1 times greater than the difference seen in the low-PRS group, corresponding to 323.1 versus 52.8 per 100,000 persons. This suggests that people with greater inherited susceptibility may benefit especially strongly from aggressive risk-factor control.
Among people aged 60 to 69 years and those 70 years or older, the fold differences between high and low MRS groups were smaller, though still meaningful. The corresponding SCI values were 500.1 versus 401.2 per 100,000 in the 60 to 69 age group and 851.2 versus 304.9 per 100,000 in those 70 years or older.
Interpretation
The study indicates that modifiable risk factors are not equally important at every age. Their relationship with pancreatic cancer appears strongest in younger adults, especially among those with high genetic risk. This finding may reflect a longer time window for harmful exposures to influence disease development, or it may indicate that a high-risk genetic background makes the pancreas more vulnerable to environmental stressors earlier in life.
Genetic risk, on the other hand, was associated with pancreatic cancer in a stable way across ages. This means inherited susceptibility remains relevant throughout adulthood, but it does not appear to intensify or diminish sharply with age in this study.
What this means for prevention
These results support the idea that prevention should begin early, not only after middle age or after symptoms appear. Reducing smoking, avoiding heavy alcohol use, improving diet quality, increasing physical activity, maintaining a healthy weight, and managing diabetes may be especially valuable in younger adults. For people with a strong family history or high polygenic risk, these measures may be even more important.
Although genetic risk cannot be changed, it can help identify individuals who may benefit from closer monitoring, counseling, and personalized prevention plans. The study adds to the growing evidence that genetic information and lifestyle data should be considered together rather than in isolation.
Clinical and public health implications
Pancreatic cancer screening is not yet recommended for the general population because the disease is relatively uncommon and current tools are limited. However, risk stratification may eventually help identify subgroups who are most likely to benefit from targeted surveillance or prevention programs. This study suggests that younger adults with high genetic susceptibility and unfavorable modifiable risk profiles may be an especially important group to consider in future strategies.
From a public health perspective, the findings reinforce a broader message: lifestyle prevention is not only for avoiding common chronic diseases such as heart disease and diabetes, but may also help reduce risk for aggressive cancers like pancreatic cancer. Early intervention may be more effective than waiting until later adulthood.
Limitations
As with all observational studies, this research cannot prove that the modifiable factors directly caused the cancer cases. There may also be unmeasured factors that influenced results. In addition, the UK Biobank population may not perfectly represent all ethnic and socioeconomic groups, so results may not generalize equally to every population.
Another important point is that risk scores summarize broad patterns and are not intended to predict an individual person’s exact outcome. A person with a high-risk score does not necessarily develop pancreatic cancer, and someone with a low-risk score is not guaranteed to be protected.
Bottom line
This large cohort study found that modifiable risk factors for pancreatic cancer are most strongly associated with disease in younger adults, especially those with high genetic risk. Genetic susceptibility remained important at all ages, but lifestyle and health-related factors showed the greatest relative impact earlier in life. The findings support early, sustained prevention efforts and a combined approach that considers both inherited and modifiable risk.
For individuals, the takeaway is clear: even when genetic risk cannot be changed, healthy behavior still matters, and it may matter most when started early.
